Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cytotherapy

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jcyt.2016.10.013PMID 27914820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach

  2018cited by this paper
• Cell Therapy for Critical Limb Ischemia

  2016cited by this paper
• Current therapies and investigational drugs for peripheral arterial disease

  2016cited by this paper
• Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells

  2016cited by this paper
• Safety and efficacy of cell-based therapy on critical limb ischemia: A meta-analysis.

  2016cited by this paper
• Critical limb ischemia: thrombogenic evaluation of two autologous cell therapy products and biologic profile in treated patients

  2015cited by this paper
• Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.

  2015cited by this paper
• Cellular senescence in aging and age-related disease: from mechanisms to therapy

  2015cited by this paper
• Hematopoietic stem cell aging.

  2014cited by this paper
• Efficacy of autologous bone marrow mononuclear cell therapy in patients with peripheral arterial disease.

  2014cited by this paper
• Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients

  2013cited by this paper
• Safety and Efficacy of Autologous Cell Therapy in Critical Limb Ischemia: A Systematic Review

  2013cited by this paper
• Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.

  2013cited by this paper
• Postischemic revascularization: from cellular and molecular mechanisms to clinical applications.

  2013cited by this paper
• Autologous Bone Marrow–Derived Cell Therapy in Patients With Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Clinical Trials

  2013cited by this paper
• Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice

  2013cited by this paper
• Platelets, inflammation and tissue regeneration

  2011cited by this paper
• Hypocellularity and insufficient expression of angiogenic factors in implanted autologous bone marrow in patients with chronic critical limb ischemia

  2011cited by this paper
• Stem cell and progenitor cell therapy in peripheral artery disease

  2010cited by this paper
• Combination Stem Cell Therapy for the Treatment of Severe Limb Ischemia: Safety and Efficacy Analysis

  2010cited by this paper
• Tissue factor up‐regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony‐forming cells without influencing non‐coagulant properties in vitro

  2010cited by this paper
• Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product

  2009cited by this paper
• Transplantation of Endothelial Progenitor Cells as Therapeutics for Cardiovascular Diseases

  2009cited by this paper
• Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary monocytes through a redox‐sensitive pathway

  2008cited by this paper
• Standardization of real-time PCR gene expression data from independent biological replicates.

  2008cited by this paper
• Aging and disease as modifiers of efficacy of cell therapy.

  2008cited by this paper
• Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.

  2008cited by this paper
• Interleukin-6 Stimulates Circulating Blood-Derived Endothelial Progenitor Cell Angiogenesis in vitro

  2008cited by this paper
• Adult mesenchymal stem cells for tissue engineering versus regenerative medicine

  2007cited by this paper
• Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies

  2007cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Critical assessment of putative endothelial progenitor phenotypes.

  2007cited by this paper
• Platelet interaction with progenitor cells: Potential implications for regenerative medicine

  2007cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk.

  2006cited by this paper
• Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans

  2006cited by this paper
• Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Molecular Evaluation of Endothelial Progenitor Cells in Patients With Ischemic Limbs: Therapeutic Effect by Stem Cell Transplantation

  2004cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003cited by this paper
• Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?

  2003cited by this paper
• Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors

  2003cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Angiogenesis by Implantation of Peripheral Blood Mononuclear Cells and Platelets Into Ischemic Limbs

  2002cited by this paper
• Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

  2000cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry

  1996cited by this paper
• Fibroblast precursors in normal and irradiated mouse hematopoietic organs.

  1976cited by this paper
• R EGENERATIVE M EDICINE Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine

  year unknowncited by this paper
• Cytokines and Matrix Metalloproteinases Progenitor Cells and Late Outgrowth Endothelial Cells: the Role of Angiogenic Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Ou

  year unknowncited by this paper

• Angiogenic Potential of Small Extracellular Vesicles Produced by Stimulated Mesenchymal Stromal Cells Under Hypoxic Conditions

  2026cites this paper
• Mesenchymal Stem Cell Based-Regenerative Therapy in Atherosclerosis: an Updated Review

  2025cites this paper
• Применение клеточных препаратов для лечения критической ишемии нижних конечностей у пациентов с сахарным диабетом: обзор литературы

  2024cites this paper
• Comparison of Three Methods for Preparation of Autologous Cells for Use in Cell Therapy of Chronic Limb-Threatening Ischemia in People with Diabetes

  2022cites this paper
• Genetically modified bone marrow mesenchymal stem cells and dental pulp mesenchymal stem cells by HIF-1alpha overexpression, differs in survival and angiogenic effects after in animal model of hind limb ischemia

  2021cites this paper
• Shear Stress Triggers Angiogenesis of Late Endothelial Progenitor Cells via the PTEN/Akt/GTPCH/BH4 Pathway

  2020cites this paper
• Cytokine Profile in Experimental Models of Critical Limb Ischemia in Rats

  2019cites this paper
• Noninvasive Monitoring of Allogeneic Stem Cell Delivery with Dual-Modality Imaging-Visible Microcapsules in a Rabbit Model of Peripheral Arterial Disease

  2019cites this paper
• In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia

  2019cites this paper
• The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu

  2019cites this paper
• Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach

  2018cites this paper
• Combined Analysis of Endothelial, Hematopoietic, and Mesenchymal Stem Cell Compartments Shows Simultaneous but Independent Effects of Age and Heart Disease

  2017cites this paper
• Efficient Differentiation of Bone Marrow Mesenchymal Stem Cells into Endothelial Cells in Vitro.

  2017cites this paper